Open original FDA record ↗Recall record
- FDA identifier
- Z-0341-2023
- Company in FDA record
- Cytocell Ltd.
- FDA classification date
- Nov 30, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates.
Source facts
- Action
- CytoCell issued Urgent Medical Device Recall letter on 10/27/22 to end user via email. The letter states reason for recall, health risk and action to take: Immediately examine your inventory and quarantine all product subject to recall. Cytocell requests that all users review and implement the enclosed new package insert (v2) for this device. Please dispose of any copies of v1 of the package insert. Please complete and return the enclosed response form as soon as possible. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or vigilance@ogt.com.
- Initiated
- 2022-10-27
- Root cause
- Under Investigation by firm
- Terminated
- 2024-12-27
- Distribution
- TX
- Recall number
- Z-0341-2023
- Recall status
- Terminated
- CDRH record ID
- 196770
- FDA classified
- 2022-11-30
- Recall event number
- 91119